Eversept Partners, LP Outset Medical, Inc. Transaction History

Eversept Partners, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$43.29 - $58.77 $2.06 Million - $2.79 Million	-47,500 Closed	0 $0
Q3 2021 Nov 08, 2023	SELL	$36.86 - $54.98 $2.2 Million - $3.29 Million	-59,800 Reduced 55.73%	47,500 $2.35 Million
Q3 2021 Nov 15, 2021	SELL	$36.86 - $54.98 $2.2 Million - $3.29 Million	-59,800 Reduced 55.73%	47,500 $2.35 Million
Q2 2021 Nov 08, 2023	BUY	$41.49 - $59.92 $4.45 Million - $6.43 Million	107,300 New	107,300 $5.36 Million
Q2 2021 Aug 16, 2021	BUY	$41.49 - $59.92 $4.45 Million - $6.43 Million	107,300 New	107,300 $5.36 Million

19.9M

66.8K

60.3K

Ticker OM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 48,007,300
Market Cap $54.2M
Description
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was ...

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Eversept Partners, LP with notifications on news.